FDA.reportPublic FDA data

Avastin

Product NDC
50242-061
11-digit product format
502420061
Labeler code
50242
Product ID
50242-061_8debebf6-af94-4ba7-8d67-c801f4ea27eb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
bevacizumab
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Genentech, Inc.
Application
BLA125085
Marketing category
BLA
Marketing start
2004-02-26
Substance
BEVACIZUMAB
Active strength
400 mg/16mL
Pharmacologic classes
Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage50242-06150242-061-10DDiscontinued by firm2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Additional Listing Data#

Finished product
Yes
Brand name base
Avastin
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BEVACIZUMAB400 mg/16mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2S9ZZM9Q9VInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1657066Internal RxNorm lookup
1657068Internal RxNorm lookup
1657073Internal RxNorm lookup
1657074Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
939b5d1f-9fb2-4499-80ef-0607aa6b114eAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
b8b10acb-0c88-4ff2-bdbd-3265dfc45b74Product name120241218
2b3a550b-5444-48ed-ac90-0bc9867c9e66Product name120170221
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50242-061-01Avastin1 in 1 CARTONINJECTION, SOLUTION139
50242-061-01Avastin16 mL in 1 VIAL, SINGLE-USEINJECTION, SOLUTION1639
50242-061-10Avastin16 mL in 1 VIAL, SINGLE-USEINJECTION, SOLUTION1639
50242-061-10Avastin10 in 1 CARTONINJECTION, SOLUTION1039

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50242-061-01ML - Milliliter50242-061a6dccae0-15f2-490b-a230-9863efa4acdf12012-07-24
50242-061-10ML - Milliliter50242-061cf015eaf-b4f6-4faa-bd02-289ad05b950f12019-06-19

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
bevacizumabACTIVE INGREDIENT2S9ZZM9Q9VAVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.]21
bevacizumabACTIVE MOIETY2S9ZZM9Q9VAVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.]21
Polysorbate 20INACTIVE INGREDIENT7T1F30V5YHAVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.]21
Sodium Phosphate, Dibasic, AnhydrousINACTIVE INGREDIENT22ADO53M6FAVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.]21
Sodium Phosphate, Monobasic, MonohydrateINACTIVE INGREDIENT593YOG76RNAVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.]21
Trehalose DihydrateINACTIVE INGREDIENT7YIN7J07X4AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.]21
WaterINACTIVE INGREDIENT059QF0KO0RAVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.]21

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50242-061AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.]39Current NDC, Legacy NDC, 4 package rows20250108_939b5d1f-9fb2-4499-80ef-0607aa6b114e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AvastinBEVACIZUMABGenentech, Inc.939b5d1f-9fb2-4499-80ef-0607aa6b114e2025-01-06Warnings, Adverse reactionsExact identifier
application number: BLA125085
ndc (product): 50242-061

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125085Avastinbevacizumab351(a)Rx2026-07-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1657068Avastin 100 MG in 4 ML InjectionPSN939b5d1f-9fb2-4499-80ef-0607aa6b114e39
1657074Avastin 400 MG in 16 ML InjectionPSN939b5d1f-9fb2-4499-80ef-0607aa6b114e39
1657066bevacizumab 100 MG in 4 ML InjectionPSN939b5d1f-9fb2-4499-80ef-0607aa6b114e39
1657073bevacizumab 400 MG in 16 ML InjectionPSN939b5d1f-9fb2-4499-80ef-0607aa6b114e39
165707416 ML bevacizumab 25 MG/ML Injection [Avastin]SBD939b5d1f-9fb2-4499-80ef-0607aa6b114e39
16570684 ML bevacizumab 25 MG/ML Injection [Avastin]SBD939b5d1f-9fb2-4499-80ef-0607aa6b114e39
165707316 ML bevacizumab 25 MG/ML InjectionSCD939b5d1f-9fb2-4499-80ef-0607aa6b114e39
16570664 ML bevacizumab 25 MG/ML InjectionSCD939b5d1f-9fb2-4499-80ef-0607aa6b114e39
1657068Avastin 100 MG per 4 ML InjectionSY939b5d1f-9fb2-4499-80ef-0607aa6b114e39
1657074Avastin 400 MG per 16 ML InjectionSY939b5d1f-9fb2-4499-80ef-0607aa6b114e39
1657066bevacizumab 100 MG per 4 ML InjectionSY939b5d1f-9fb2-4499-80ef-0607aa6b114e39
1657073bevacizumab 400 MG per 16 ML InjectionSY939b5d1f-9fb2-4499-80ef-0607aa6b114e39

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
50242-061-01502420061011 VIAL, SINGLE-USE in 1 CARTON (50242-061-01) / 16 mL in 1 VIAL, SINGLE-USE2004-02-260000-00-00NoNoCurrent
50242-061-105024200611010 VIAL, SINGLE-USE in 1 CARTON (50242-061-10) > 16 mL in 1 VIAL, SINGLE-USE2019-04-012023-02-28NoNoCurrent